Annual FCF
-$184.46 M
-$27.73 M-17.70%
December 31, 2024
Summary
- As of March 12, 2025, XENE annual free cash flow is -$184.46 million, with the most recent change of -$27.73 million (-17.70%) on December 31, 2024.
- During the last 3 years, XENE annual FCF has fallen by -$112.91 million (-157.80%).
- XENE annual FCF is now -509.49% below its all-time high of $45.05 million, reached on December 31, 2012.
Performance
XENE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$55.17 M
-$3.43 M-6.63%
December 31, 2024
Summary
- As of March 12, 2025, XENE quarterly free cash flow is -$55.17 million, with the most recent change of -$3.43 million (-6.63%) on December 31, 2024.
- Over the past year, XENE quarterly FCF has stayed the same.
- XENE quarterly FCF is now -387.45% below its all-time high of $19.19 million, reached on December 31, 2019.
Performance
XENE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$184.46 M
-$19.69 M-11.95%
December 31, 2024
Summary
- As of March 12, 2025, XENE TTM free cash flow is -$184.46 million, with the most recent change of -$19.69 million (-11.95%) on December 31, 2024.
- Over the past year, XENE TTM FCF has stayed the same.
- XENE TTM FCF is now -7586.36% below its all-time high of $2.46 million, reached on September 30, 2014.
Performance
XENE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XENE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | 0.0% | 0.0% |
| 3 y3 years | -157.8% | -196.0% | -167.0% |
| 5 y5 years | -2998.2% | -196.0% | -167.0% |
XENE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -157.8% | at low | -216.8% | at low | -167.0% | at low |
| 5 y | 5-year | -2998.2% | at low | -387.4% | at low | -2998.2% | at low |
| alltime | all time | -509.5% | at low | -387.4% | at low | -7586.4% | at low |
Xenon Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$184.46 M(+17.7%) | -$55.17 M(+6.6%) | -$184.46 M(+11.9%) |
| Sep 2024 | - | -$51.74 M(+51.3%) | -$164.78 M(+1.5%) |
| Jun 2024 | - | -$34.19 M(-21.2%) | -$162.32 M(-0.7%) |
| Mar 2024 | - | -$43.37 M(+22.2%) | -$163.48 M(+4.3%) |
| Dec 2023 | -$156.73 M(+50.8%) | -$35.48 M(-28.0%) | -$156.73 M(-1.0%) |
| Sep 2023 | - | -$49.28 M(+39.4%) | -$158.33 M(+13.2%) |
| Jun 2023 | - | -$35.35 M(-3.4%) | -$139.84 M(+14.7%) |
| Mar 2023 | - | -$36.62 M(-1.3%) | -$121.90 M(+17.3%) |
| Dec 2022 | -$103.92 M(+45.2%) | -$37.08 M(+20.4%) | -$103.92 M(+18.0%) |
| Sep 2022 | - | -$30.79 M(+76.8%) | -$88.06 M(+21.5%) |
| Jun 2022 | - | -$17.41 M(-6.6%) | -$72.51 M(+5.0%) |
| Mar 2022 | - | -$18.64 M(-12.2%) | -$69.08 M(-3.5%) |
| Dec 2021 | -$71.55 M(+41.0%) | -$21.22 M(+39.4%) | -$71.55 M(+11.3%) |
| Sep 2021 | - | -$15.23 M(+8.9%) | -$64.27 M(+5.4%) |
| Jun 2021 | - | -$13.99 M(-33.8%) | -$60.99 M(+4.9%) |
| Mar 2021 | - | -$21.11 M(+51.4%) | -$58.16 M(+14.6%) |
| Dec 2020 | -$50.76 M(+752.6%) | -$13.94 M(+16.7%) | -$50.76 M(+188.0%) |
| Sep 2020 | - | -$11.95 M(+7.1%) | -$17.63 M(+37.9%) |
| Jun 2020 | - | -$11.16 M(-18.6%) | -$12.78 M(+20.2%) |
| Mar 2020 | - | -$13.71 M(-171.5%) | -$10.64 M(+78.7%) |
| Dec 2019 | -$5.95 M | $19.19 M(-370.2%) | -$5.95 M(-81.7%) |
| Sep 2019 | - | -$7.10 M(-21.2%) | -$32.56 M(-16.9%) |
| Jun 2019 | - | -$9.01 M(-0.2%) | -$39.20 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$9.03 M(+21.8%) | -$35.86 M(+1.8%) |
| Dec 2018 | -$35.23 M(+21.3%) | -$7.41 M(-46.1%) | -$35.23 M(+1.5%) |
| Sep 2018 | - | -$13.74 M(+142.2%) | -$34.72 M(+17.2%) |
| Jun 2018 | - | -$5.67 M(-32.4%) | -$29.62 M(-4.0%) |
| Mar 2018 | - | -$8.40 M(+21.7%) | -$30.84 M(+6.2%) |
| Dec 2017 | -$29.04 M(+46.3%) | -$6.90 M(-20.1%) | -$29.04 M(+8.2%) |
| Sep 2017 | - | -$8.64 M(+25.2%) | -$26.84 M(+17.9%) |
| Jun 2017 | - | -$6.90 M(+4.6%) | -$22.77 M(+6.3%) |
| Mar 2017 | - | -$6.60 M(+40.4%) | -$21.42 M(+7.9%) |
| Dec 2016 | -$19.85 M(+6.4%) | -$4.70 M(+2.8%) | -$19.85 M(-3.4%) |
| Sep 2016 | - | -$4.57 M(-17.7%) | -$20.54 M(-2.5%) |
| Jun 2016 | - | -$5.55 M(+10.4%) | -$21.07 M(+16.7%) |
| Mar 2016 | - | -$5.03 M(-6.7%) | -$18.05 M(-3.2%) |
| Dec 2015 | -$18.65 M(+1377.0%) | -$5.39 M(+5.6%) | -$18.65 M(+9.8%) |
| Sep 2015 | - | -$5.10 M(+101.7%) | -$16.99 M(+189.9%) |
| Jun 2015 | - | -$2.53 M(-55.1%) | -$5.86 M(+5.2%) |
| Mar 2015 | - | -$5.63 M(+51.1%) | -$5.57 M(+341.2%) |
| Dec 2014 | -$1.26 M(-63.7%) | -$3.73 M(-161.8%) | -$1.26 M(-151.3%) |
| Sep 2014 | - | $6.03 M(-368.9%) | $2.46 M(-169.1%) |
| Jun 2014 | - | -$2.24 M(+69.6%) | -$3.56 M(+169.6%) |
| Mar 2014 | - | -$1.32 M | -$1.32 M |
| Dec 2013 | -$3.48 M(-107.7%) | - | - |
| Dec 2012 | $45.05 M(-422.2%) | - | - |
| Dec 2011 | -$13.98 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual FCF year-on-year change?
- What is Xenon Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly FCF year-on-year change?
- What is Xenon Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM FCF year-on-year change?
What is Xenon Pharmaceuticals annual free cash flow?
The current annual FCF of XENE is -$184.46 M
What is the all time high annual FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual free cash flow is $45.05 M
What is Xenon Pharmaceuticals annual FCF year-on-year change?
Over the past year, XENE annual free cash flow has changed by -$27.73 M (-17.70%)
What is Xenon Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of XENE is -$55.17 M
What is the all time high quarterly FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly free cash flow is $19.19 M
What is Xenon Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, XENE quarterly free cash flow has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals TTM free cash flow?
The current TTM FCF of XENE is -$184.46 M
What is the all time high TTM FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM free cash flow is $2.46 M
What is Xenon Pharmaceuticals TTM FCF year-on-year change?
Over the past year, XENE TTM free cash flow has changed by $0.00 (0.00%)